Abracadabra DAO has passed a proposal to shut down the protocol. The project once held more than $6 billion in locked funds. MIM holders will receive just 4 cents on the dollar.

Anthropic plans to buy more than $20 billion in compute services from AMD. AMD has committed to invest up to $5 billion for a stake in Anthropic.

Consensys sold all 5.7 million SBET shares at $8.39 apiece, 93% below the stock's May 2025 peak. The shares fell another 11% yesterday.

A key committee has approved new rules on "non-operating companies" that could remove Strategy from the MSCI World Index. The stock fell 4% in after-hours trading. With a float-adjusted market value of about $40 billion, Strategy is the largest of all the candidates for removal. JPMorgan has estimated the company could face roughly $2.8 billion in passive outflows if it is dropped from the index.

Longview Asset Management, the Henry Crown family office and General Dynamics’ largest shareholder, reduced its holding by nearly 10% between August 26 and October 1, selling about $1 billion of stock. In September, the firm accounted for 9.6% of all General Dynamics shares traded, while the stock fell 13% over the same period. The sales stood out as broader markets strengthened, with the S&P 500 rising during that time.

The Office of the Comptroller of the Currency said American Express National Bank processed about $13 billion in suspected trade-based money laundering transactions from June 2014 to May 2025, including activity routed through accounts tied to bank insiders. American Express agreed to pay a $350 million penalty under an OCC consent order after the agency found the bank failed to maintain an effective Bank Secrecy Act and anti-money laundering compliance program.

Data provider Ortex estimates that about 99% of MiniMed Group Inc.’s public float has been sold short, a sharp jump from prior levels. Ortex’s securities-lending data show borrow availability at just 0.08% of short interest. The report says the extreme figures may reflect arbitrage tied to Medtronic’s 90% stake and its stock-for-stock exchange offer, rather than a straightforward bearish bet.

Since launching its buyback program in June 2022, Nike has spent about $12.1 billion to repurchase 124.4 million shares at an average price of $97.57. The stock opened at $33.70, about 65% below the average buyback price, implying an opportunity cost of roughly $7.9 billion. Nike’s market capitalization has fallen from $187 billion in June 2022 to $51 billion, while the shares are down 46% year-to-date. The buyback program is currently paused, with $5.9 billion remaining under the authorization.